Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Autolus Therapeutics (AUTL) Other Non-Current Liabilities: 2018-2025

Historic Other Non-Current Liabilities for Autolus Therapeutics (AUTL) over the last 6 years, with Sep 2025 value amounting to $472,000.

  • Autolus Therapeutics' Other Non-Current Liabilities rose 5.59% to $472,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $472,000, marking a year-over-year increase of 5.59%. This contributed to the annual value of $426,000 for FY2024, which is 19.33% up from last year.
  • Per Autolus Therapeutics' latest filing, its Other Non-Current Liabilities stood at $472,000 for Q3 2025, which was down 1.05% from $477,000 recorded in Q2 2025.
  • Over the past 5 years, Autolus Therapeutics' Other Non-Current Liabilities peaked at $678.0 million during Q2 2021, and registered a low of $105,000 during Q3 2022.
  • For the 3-year period, Autolus Therapeutics' Other Non-Current Liabilities averaged around $361,636, with its median value being $415,000 (2024).
  • In the last 5 years, Autolus Therapeutics' Other Non-Current Liabilities tumbled by 99.98% in 2022 and then surged by 258.77% in 2024.
  • Over the past 5 years, Autolus Therapeutics' Other Non-Current Liabilities (Quarterly) stood at $128,000 in 2021, then fell by 9.38% to $116,000 in 2022, then soared by 207.76% to $357,000 in 2023, then grew by 19.33% to $426,000 in 2024, then climbed by 5.59% to $472,000 in 2025.
  • Its last three reported values are $472,000 in Q3 2025, $477,000 for Q2 2025, and $444,000 during Q1 2025.